His research integrates microbiology, drug delivery, and natural product-based drug discovery, placing him in a unique position to develop therapeutically effective and microbiologically sound pharmaceutical formulations. His work spans the identification and evaluation of bioactive compounds from natural plant sources, as well as the design of advanced drug delivery systems to overcome biological barriers and enhance therapeutic outcomes. With particular expertise in pulmonary and nose-to-brain delivery, he focuses on translating natural compounds into innovative formulations for the treatment of infectious diseases, respiratory disorders, and neurological conditions. This multidisciplinary approach enables the development of evidence-based, targeted therapies that combine the therapeutic potential of natural products with cutting-edge pharmaceutical technologies.